Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|22|1|petr.13093-petr.13093

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.22, Iss.1, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Managing risk of surgical procedures in pediatric transplant recipients taking mTOR inhibitors: What is the optimal strategy?

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bullous pemphigoid induced by m‐TOR inhibitors in renal transplant recipients

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1626-1630

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychosocial functioning in pediatric heart transplant recipients and their families

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bronchoscopic procedures and lung biopsies in pediatric lung transplant recipients

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 12, 2015-12 ,pp. : 1406-1419

John Wiley & Sons Inc

Access to resources Recommend Favorite

Longitudinal renal function in pediatric heart transplant recipients: 20‐years experience

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 2, 2015-03 ,pp. : 182-187

John Wiley & Sons Inc

Access to resources Recommend Favorite